Xeris Pharmaceuticals Inc reported $84.11M in Cash and Equivalent for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Acelrx Pharmaceuticals ACRX:US USD 12.73M 2.43M
Endo International Ordinary Shares ENDP:US USD 1.05B 137.68M
Horizon Pharma HZNP:US USD 2.13B 237.96M
Jazz Pharmaceuticals JAZZ:US USD 482.67M 191.74M
Nektar Therapeutics NKTR:US USD 105.76M 28.21M
Pacira Pharmaceuticals PCRX:US USD 109.42M 12.64M
Perrigo Ordinary Shares PRGO:US USD 468.7M 16.6M
Supernus Pharmaceuticals SUPN:US USD 111.49M 61.94M
Teva Pharmaceutical Industries TEVA:US USD 2.22B 167M